Glycolax side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Glycolax. Common side effects include abdominal pain among females, and abdominal distension among males.
The phase IV clinical study is created by eHealthMe based on 1,945 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,945 people who take Glycolax and have side effects are studied.
What is Glycolax?
Glycolax has active ingredients of polyethylene glycol 3350. Currently, eHealthMe is studying from 1,951 Glycolax users.
Number of Glycolax reports submitted per year:
Glycolax side effects by time on the drug *:
Glycolax side effects by gender *:
Glycolax side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Glycolax?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on polyethylene glycol 3350 (the active ingredients of Glycolax) and Glycolax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Glycolax:
- Glycolax (1,951 reports)
Common Glycolax side effects:
- Constipation: 236 reports
- Weakness: 232 reports
- Pain: 229 reports
- Stress and anxiety: 207 reports
- Breathing difficulty: 183 reports
All Glycolax side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Multivitamin and Besremi drug interaction - now
- Milk Thistle and Arrhythmias - 4 seconds ago
- Rocephin and Duoneb drug interaction - 16 seconds ago
- Prohance and Rashes - 27 seconds ago
- Tylenol and Hepatic Haemorrhage - 40 seconds ago
- Sertraline and Paliperidone Palmitate drug interaction - 46 seconds ago
- Darvocet-N 50 and Mycelex drug interaction - 48 seconds ago
- Robitussin and Meclizine Hydrochloride drug interaction - 48 seconds ago
- Tamsulosin and Hepatotoxicity - 48 seconds ago
- Demadex and Blood Alkaline Phosphatase Nos Increased - 51 seconds ago